EMA Authorised: Epidyolex (cannabidiol) — Jazz Pharmaceuticals Ireland Limited

View source ↗

Summary

Authorised cannabidiol medicine Epidyolex for Lennox-Gastaut syndrome and other epilepsies with myoclonic features.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsies with Myoclonic Features
• Lennox-gastaut Syndrome

Drugs mentioned

• Epidyolex (cannabidiol)

Snippet

Status: Authorised. Therapeutic area: Lennox Gastaut Syndrome;Epilepsies, Myoclonic. MAH: Jazz Pharmaceuticals Ireland Limited. Decision date: 16/07/2026. Orphan medicine